NHS National Generic Pharmaceuticals - Wave 16a

NHS National Framework for Generics Pharmaceuticals Wave 16a

Offer reference number: CM/PHG/24/5714

Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:

CM/PHG/24/5714/01 Oral (plus non-parenteral) products:

CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)

CM/PHG/24/5714/02 Hospital only products:

DLN: 01/02/2027 to 31/01/2029 (24 months)

DNW: 01/02/2027 to 31/01/2029 (24 months)

CM/PHG/24/5714/03 Hospital only (housekeeping) products:

DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)

DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)